• Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
Search
FDAReview.org
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About

Blog

Featured posts
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Medical Apps: Improving Healthcare on a Global Scale

Raymond March - March 1, 2018

Politics Is Costing Lives by Delaying Right-to-Try Legislation

New Blood-Pressure Guidelines Raise Concerns about Interest-Group Lobbying

The FDA Cannot Hire Staff with Starting Salaries of $160,000

Recent Posts

  • When Healthy Policy Neglects Economic Principles, Patients Suffer
  • FDA Still Hooked on Meddling in Nicotine Markets
  • FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple Syrup
  • Let Competition, Not the FDA, Resolve the EpiPen Shortage
  • Government vs. Private Efforts to Promote Breastfeeding: My Response to a Critic

Archives

  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • December 2017
  • April 2016
© 2018 Independent Institute, 100 Swan Way, Oakland CA 94621-1428 | (510) 632‑1366.
Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.